Reporting positive treatment outcomes with bendamustine + rituximab in indolent lymphomas
Liquid biospy approaches for detecting MM and their optimization
Immunotherapy for multiple myeloma: current research avenues
Can CAR T-cells be optimised to safely treat MM patients?
Developments that are changing the treatment of CLL - current and future drugs